Alberto Santagostino Appointed As Chief Executive Officer and President of Agc Biologics
Oct 28, 2024•9 months ago
Position
President
Company
AGC Biologics
Description
AGC Biologics announced the appointment of Alberto Santagostino as the new Chief Executive Officer and President, effective November 1st. Alberto brings a distinguished career in biotech, pharma, and managing large-scale global CDMO operations, and will lead the company in delivering reliable services to biopharmaceutical developers without unnecessary complications.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months